Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

UHRF1 Activators

The class of UHRF1 activators pertains to compounds that modulate the activity of Ubiquitin-like with PHD and RING Finger domains 1 (UHRF1), a multifaceted epigenetic regulator known for its pivotal role in the maintenance of DNA methylation patterns and chromatin structure. UHRF1 is a nuclear protein that orchestrates the coordination of several key epigenetic processes, including DNA methylation and histone modifications. Its significance lies in its ability to recognize hemi-methylated DNA, a hallmark of DNA replication, and recruit DNA methyltransferases for the faithful propagation of DNA methylation patterns during cellular division. UHRF1, often referred to as the "epigenetic guardian of the genome," possesses several functional domains, including a ubiquitin-like domain, a tandem Tudor domain, a plant homeodomain (PHD), and a RING finger domain. These domains collectively contribute to its multifaceted roles in epigenetic regulation. The ubiquitin-like domain enables UHRF1 to interact with chromatin, facilitating its recruitment to specific genomic loci. The PHD and Tudor domains are involved in recognizing and binding to histone modifications, thereby linking DNA methylation and histone modification pathways.

Activation of UHRF1 involves intricate molecular mechanisms that finely tune its epigenetic functions. The recruitment of UHRF1 to chromatin is facilitated by its interaction with various partner proteins and post-translational modifications. Additionally, the coordination of UHRF1 with cell cycle progression ensures its involvement in the maintenance of epigenetic marks during DNA replication. The binding of UHRF1 to hemi-methylated DNA marks sites for de novo DNA methylation, crucial for the perpetuation of epigenetic information across generations of cells. Importantly, the interplay between UHRF1 and other epigenetic regulators, such as DNA methyltransferases and histone-modifying enzymes, can intricately modulate the epigenetic landscape. Understanding the activation of UHRF1 can provide insights into the regulatory networks that govern epigenetic stability. The modulation of UHRF1 activity by specific activators can potentially influence its functions in epigenetic maintenance.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

Induces DNA demethylation, potentially affecting UHRF1's role in DNA methylation maintenance.

Ademetionine

29908-03-0sc-278677
sc-278677A
100 mg
1 g
$184.00
$668.00
2
(1)

Acts as a methyl donor in various methylation processes, potentially modulating UHRF1 activity.

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$133.00
$275.00
37
(2)

A histone deacetylase inhibitor, may influence UHRF1 through histone modification pathways.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Another histone deacetylase inhibitor, can have an indirect effect on UHRF1.

Valproic Acid

99-66-1sc-213144
10 g
$87.00
9
(1)

A histone deacetylase inhibitor, potentially affects UHRF1 function in chromatin remodeling.

Nicotinamide

98-92-0sc-208096
sc-208096A
sc-208096B
sc-208096C
100 g
250 g
1 kg
5 kg
$44.00
$66.00
$204.00
$831.00
6
(1)

A sirtuin inhibitor that can indirectly influence UHRF1 through histone modification.

Methylstat

1310877-95-2sc-507374
10 mg
$480.00
(0)

A Jumonji C domain-containing protein inhibitor, might indirectly affect UHRF1 activities.

Disulfiram

97-77-8sc-205654
sc-205654A
50 g
100 g
$53.00
$89.00
7
(1)

Alters DNA methylation patterns, potentially impacting UHRF1 function.

Zebularine

3690-10-6sc-203315
sc-203315A
sc-203315B
10 mg
25 mg
100 mg
$129.00
$284.00
$1004.00
3
(1)

A DNA methyltransferase inhibitor, can indirectly affect UHRF1's DNA methylation role.

5-Aza-2′-Deoxycytidine

2353-33-5sc-202424
sc-202424A
sc-202424B
25 mg
100 mg
250 mg
$218.00
$322.00
$426.00
7
(1)

Another DNA methyltransferase inhibitor, potentially influencing UHRF1 activity.